Education
About Us
Working with TipRanks
Follow Us
Walgreens Boots Alliance (WBA)
NASDAQ:WBA
WBA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.08 - $18.83
Previous CloseN/A
Volume6.88M
Average Volume (3M)23.16M
Market Cap
$9.32B
Enterprise Value$39.35B
Total Cash (Recent Filing)$2.50B
Total Debt (Recent Filing)$2.35B
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Jun 26, 2025EPS Estimate
0.33Last Dividend Ex-Date
Nov 18, 2024Dividend Yield9.28%
Share Statistics
EPS (TTM)-6.69
Shares Outstanding864,737,900
10 Day Avg. Volume18,124,857
30 Day Avg. Volume23,158,757
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.06
Price to Cash Flow (P/CF)-17.10
P/FCF Ratio0.00
Enterprise Value/Market Cap4.22
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.48
Enterprise Value/Ebitda-3.31
Forecast
1Y Price Target
$11.50Price Target Upside6.68% Upside
Rating ConsensusHold
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Deal FinancingSycamore has secured fully committed financing for the transaction.
Private Equity TakeoverA private equity takeover could provide WBA with additional flexibility to address operational challenges in the private market.
ProfitabilityUS Healthcare's profitability improved significantly, driven by contributions from VillageMD and Shields.
Bears Say
Cash Flow And Debt ChallengesThere are concerns about WBA's lack of cash flow and upcoming debt challenges, which could complicate a potential deal.
Lack Of GuidanceGuidance was withdrawn due to the Sycamore deal and there will be no conference call to discuss results.
Market CompetitionCVS has been gaining share vs. the market, including WBA, for a few years.
---
Ownership Overview
17.70% Insiders
13.42% Mutual Funds
8.98% Other Institutional Investors
34.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Walgreens Boots Alliance
Desktop Users
Mobile Users
WBA FAQ
What was Walgreens Boots Alliance’s price range in the past 12 months?
Walgreens Boots Alliance lowest stock price was $8.08 and its highest was $18.83 in the past 12 months.
What is Walgreens Boots Alliance’s market cap?
Walgreens Boots Alliance’s market cap is $9.32B.
When is Walgreens Boots Alliance’s upcoming earnings report date?
Walgreens Boots Alliance’s upcoming earnings report date is Jun 26, 2025 which is in 75 days.
How were Walgreens Boots Alliance’s earnings last quarter?
Walgreens Boots Alliance released its earnings results on Apr 08, 2025. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.535 by $0.095.
Is Walgreens Boots Alliance overvalued?
According to Wall Street analysts Walgreens Boots Alliance’s price is currently Undervalued.
Does Walgreens Boots Alliance pay dividends?
Walgreens Boots Alliance pays a Quarterly dividend of $0.25 which represents an annual dividend yield of 9.28%. See more information on Walgreens Boots Alliance dividends here
What is Walgreens Boots Alliance’s EPS estimate?
Walgreens Boots Alliance’s EPS estimate is 0.33.
How many shares outstanding does Walgreens Boots Alliance have?
Walgreens Boots Alliance has 864,737,900 shares outstanding.
What happened to Walgreens Boots Alliance’s price movement after its last earnings report?
Walgreens Boots Alliance reported an EPS of $0.63 in its last earnings report, beating expectations of $0.535. Following the earnings report the stock price went down -1.12%.
Which hedge fund is a major shareholder of Walgreens Boots Alliance?
Currently, no hedge funds are holding shares in WBA
---
Walgreens Boots Alliance Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$11.50 (6.68% Upside)
$11.50 (6.68% Upside)
Blogger Sentiment
Neutral
WBA Sentiment 62%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 4.3%
Last 30 Days ▼ 4.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-36.54%
12-Months-Change
Fundamentals
Return on Equity
-56.13%
Trailing 12-Months
Asset Growth
-16.61%
Trailing 12-Months
Company Description
Walgreens Boots Alliance
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
---
WBA Company Deck
---
WBA Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong sales growth across all segments, improved free cash flow, and positive performance in the pharmacy and healthcare segments. However, it also noted challenges with declining retail sales in the U.S. and a significant decline in adjusted EPS. Despite these challenges, the company remains focused on executing its turnaround strategy.Read More>---
WBA Revenue Breakdown
78.41% U.S. Retail Pharmacy
15.95% International
5.65% U.S. Healthcare
---
WBA Stock 12 Month Forecast
Average Price Target
$11.50
▲(6.68% Upside)
Technical Analysis
Best Analysts Covering WBA
1 Year
1 Year Success Rate
6/23 ratings generated profit
1 Year Average Return
-16.99%
reiterated a buy rating last month
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 26.09% of your transactions generating a profit, with an average return of -16.99% per trade.
---